Latest filings (excl ownership)
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8 May 24
10-K
2023 FY
Annual report
17 Apr 24
8-K
Entry into a Material Definitive Agreement
5 Apr 24
NT 10-K
Notice of late annual filing
1 Apr 24
8-K
Entry into a Material Definitive Agreement
12 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
11 Mar 24
DEF 14A
Definitive proxy
26 Feb 24
PRER14A
Preliminary revised proxy
20 Feb 24
PRE 14A
Preliminary proxy
6 Feb 24
10-Q
2023 Q2
Quarterly report
12 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
2 Jan 24
DEF 14A
Definitive proxy
19 Dec 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5 Dec 23
NT 10-Q
Notice of late quarterly filing
15 Nov 23
425
Business combination disclosure
9 Nov 23
8-K
Other Events
9 Nov 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
2 Oct 23
8-K
Amendments to Articles of Incorporation or Bylaws
12 Sep 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
28 Aug 23
DEF 14A
Definitive proxy
28 Aug 23
10-Q
2023 Q2
Quarterly report
28 Aug 23
PRER14A
Preliminary revised proxy
16 Aug 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
PRER14A
Preliminary revised proxy
14 Aug 23
PRE 14A
Preliminary proxy
11 Aug 23
8-K
Departure of Directors or Certain Officers
2 Jun 23
10-Q
2023 Q1
Quarterly report
22 May 23
NT 10-Q
Notice of late quarterly filing
15 May 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
2 May 23
10-K
2022 FY
Annual report
18 Apr 23
NT 10-K
Notice of late annual filing
31 Mar 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
31 Mar 23
8-K
Departure of Directors or Certain Officers
19 Jan 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
28 Dec 22
8-K
Amendments to Articles of Incorporation or Bylaws
23 Dec 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
20 Dec 22
425
Business combination disclosure
1 Dec 22
8-K
Liminatus Pharma LLC and Iris Acquisition Corp to combine to incorporate and accelerate much-needed cancer treatments
1 Dec 22
DEF 14A
Definitive proxy
28 Nov 22
Latest ownership filings
SC 13G/A
MOORE CAPITAL MANAGEMENT, LP
14 Feb 24
SC 13G/A
Polar Asset Management Partners Inc.
13 Feb 24
4
Boaz Weinstein
28 Sep 23
SC 13G/A
Saba Capital Management, L.P.
27 Sep 23
3
LOUIS M BACON
26 Sep 23
SC 13G
Saba Capital Management, L.P.
23 Feb 23
3
Boaz Weinstein
23 Feb 23
SC 13G
MOORE CAPITAL MANAGEMENT, LP
14 Feb 23
SC 13G/A
Beryl Capital Management LLC
14 Feb 23
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 23
3
Shashibhushan Borade
27 Jan 23
SC 13G
Beryl Capital Management LLC
12 Dec 22
3
Manish C. Shah
14 Sep 22
3
Lisha Parmar
16 Aug 22
3
Omkar Halady
16 Aug 22
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 22
SC 13G
Polar Asset Management Partners Inc.
11 Feb 22
SC 13G
CITADEL ADVISORS LLC
27 May 21
3
Rohit Nanani
5 Mar 21
3
Henry S. Ward
4 Mar 21
3
Richard N. Peretz
4 Mar 21
3
Sumit Mehta
4 Mar 21
3
Ted Maidenberg
4 Mar 21
3
Initial statement of insider ownership
4 Mar 21
3
Arjun Sethi
4 Mar 21
3
Duriya M Farooqui
4 Mar 21
3
Omar Chohan
4 Mar 21